You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

PROMETH VC PLAIN Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Prometh Vc Plain, and what generic alternatives are available?

Prometh Vc Plain is a drug marketed by G And W Labs Inc and is included in one NDA.

The generic ingredient in PROMETH VC PLAIN is phenylephrine hydrochloride; promethazine hydrochloride. There are twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride; promethazine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Prometh Vc Plain

A generic version of PROMETH VC PLAIN was approved as phenylephrine hydrochloride; promethazine hydrochloride by GENUS on December 7^th, 2006.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for PROMETH VC PLAIN?
What are the global sales for PROMETH VC PLAIN?
What is Average Wholesale Price for PROMETH VC PLAIN?

Summary for PROMETH VC PLAIN

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	2
Clinical Trials:	1
Patent Applications:	1
DailyMed Link:	PROMETH VC PLAIN at DailyMed

Drug patent expirations by year for PROMETH VC PLAIN

Recent Clinical Trials for PROMETH VC PLAIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
M.D. Anderson Cancer Center	N/A

See all PROMETH VC PLAIN clinical trials

US Patents and Regulatory Information for PROMETH VC PLAIN

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
G And W Labs Inc	PROMETH VC PLAIN	phenylephrine hydrochloride; promethazine hydrochloride	SYRUP;ORAL	088761-001	Nov 8, 1984		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.